Blue Rock Advisors’s Labcorp LH Stock Holding History

Blue Rock Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,402	Closed	-$3.62M	–	62
2020 Q3	$3.62M	Buy	+22,402	New	+$3.55M	3.13%	5

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Blue Rock Advisors's LH Position: Q4 2020 in Review

Blue Rock Advisors sold out of Labcorp (LH) in Q4 2020, closing a stake of 22,402 shares — an estimated $3.62M sold.

Blue Rock Advisors first reported a position in LH in Q3 2020 and held it in 1 quarter. The position peaked at $3.62M in Q3 2020. 907 funds tracked by Wall St. Rank hold LH as of Q4 2020.

Blue Rock Advisors reported no remaining Labcorp position as of Q4 2020 after selling out during the quarter.
Blue Rock Advisors sold 22,402 Labcorp shares in Q4 2020, an estimated $3.62M.
Blue Rock Advisors first reported a position in Labcorp in Q3 2020 and held it in 1 quarter.
Blue Rock Advisors's Labcorp position peaked at $3.62M in Q3 2020.
907 funds tracked by Wall St. Rank held Labcorp as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.